NCT02639650 2022-06-03
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Women's Hospital School Of Medicine Zhejiang University
Phase 3 Unknown
Women's Hospital School Of Medicine Zhejiang University
Huazhong University of Science and Technology
Tufts Medical Center
Memorial Sloan Kettering Cancer Center